The prevalence and disease burden of severe eosinophilic asthma in Japan

References

• Brusselle GG, Msaes T, Bracke KR. Eosinophils in the spotlight: eosinophilic airway inflammation in nonallergic asthma. Nat Med 2013;19:977–979.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Asthma. Available from: http://www.who.int/mediacentre/factsheets/fs307/en/.
   Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. 2015. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Report_2015_May19.pdf.
   Google Scholar
• GBD Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1545–1602.
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Koya T, Sakagami T, Toyabe S, Kagamu H, Arakawa M, Gejyo F, et al. Asthma control and management changes in Japan: questionnaire survey. Intern Med (Tokyo, Japan) 2012;51:567–574.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Bronchial asthma. Available from: http://www.who.int/mediacentre/factsheets/fs206/en/.
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43:343–373.
   PubMed Web of Science ®Google Scholar
• Nagasaki T, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Kita H, Horiguchi T, et al. Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes. J Allergy Clin Immunol 2014;133:1474–1477.e2.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218–224.
   PubMed Web of Science ®Google Scholar
• Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715–1721.
   PubMed Web of Science ®Google Scholar
• Hinks TSC, Brown T, Lau LCK, Rupani H, Barber C, Elliott S, Ward JA, et al. Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1. J Allergy Clin Immunol 2016;138:61–75.
   PubMed Web of Science ®Google Scholar
• Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy 2016;9:1–12.
   PubMed Web of Science ®Google Scholar
• ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004;170:601–605.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368:804–813.
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, Chen W, Khatry DB, Gossage D, Tran TN, et al. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunol Pract 2014;2:741–750.
   PubMed Web of Science ®Google Scholar
• Casciano J, Krishnan J, Dotiwala Z, Li C, Sun SX. Clinical and economic burden of elevated blood eosinophils in patients with and without uncontrolled asthma. J Manag Care Spec Pharm 2017;23:85–91.
   PubMed Web of Science ®Google Scholar
• Casciano J, Krishnan JA, Small MB, Buck PO, Gopalan G, Li C, Kemp R, et al. Burden of asthma with elevated blood eosinophil levels. BMC Pulm Med 2016;16:100.
   PubMed Web of Science ®Google Scholar
• Ohta K, Ichinose M, Nagase H, Yamaguchi M, Sugiura H, Tohda Y, Yamauchi K, et al. Japanese guideline for adult asthma 2014. Allergol Int 2014;63:293–333.
   PubMed Web of Science ®Google Scholar
• Japanese National Health Insurance medical fee point scheme 2014. Available from: http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000032996.html.
   Google Scholar
• Hastie AT, Moore WC, Li H, Rector BM, Ortega VE, Pascual RM, Peters SP, et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol 2013;132:72–80.
   PubMed Web of Science ®Google Scholar
• Price DB, Rigazio A, Campbell JD, Bleecker ER, Corrigan CJ, Thomas M, Wenzel SE, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med 2015;3:849–858.
   PubMed Web of Science ®Google Scholar
• van Veen IH, ten Brinke A, Gauw SA, Sterk PJ, Rabe KF, Bel EH. Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study. J Allergy Clin Immunol 2009;124:615–617. e2.
   PubMed Web of Science ®Google Scholar
• de Groot JC, ten Brinke A, Bel EH. Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res 2015;1:00024-2015.
   PubMedGoogle Scholar
• Barnes PJ. Intrinsic asthma: not so different from allergic asthma but driven by superantigens? Clin Exp Allergy 2009;39:1145–1151.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Kanemitsu Y, Nagasaki T, Tohda Y, Horiguchi T, Kita H, Kuwabara K, et al. Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes. Ann Allergy Asthma Immunol 2017;118:197–203.
   PubMed Web of Science ®Google Scholar
• Berry M, Morgan A, Shaw DE, Parker D, Green R, Brightling C, Bradding P, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007;62:1043–1049.
   PubMed Web of Science ®Google Scholar
• Konno S, Taniguchi N, Makita H, Nakamaru Y, Shimizu K, Shijubo N, Fuke S, et al. Distinct phenotypes of smokers with fixed airflow limitation identified by cluster analysis of severe asthma. Ann Am Thorac Soc 2018;15:33–41.
   PubMed Web of Science ®Google Scholar
• Matsusaka M, Fukunaga K, Kabata H, Izuhara K, Asano K, Betsuyaku T. Subphenotypes of type 2 severe asthma in adults. J Allergy Clin Immunol Pract 2018;6:274–276 e2.
   PubMed Web of Science ®Google Scholar
• Suruki RY, Daugherty JB, Boudiaf N, Albers FC. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med 2017;17:74.
   PubMed Web of Science ®Google Scholar
• Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Ann Am Thorac Soc 2014;11:531–536.
   PubMedGoogle Scholar
• Ortega H, Katz L, Gunsoy N, Keene O, Yancey S. Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthma. J Allergy Clin Immunol 2015;136:825–826.
   PubMed Web of Science ®Google Scholar